The Safety, Tolerability and Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults without Previous Smallpox Vaccination A Double-Blind, Placebo-Controlled, Dose-Ranging Study Followed by a Challenge

Grants and Contracts Details

StatusFinished
Effective start/end date3/29/04 → 2/28/10

Funding

  • Acambis Inc: $421,593.00